The Use Of Blood-Based Biomarkers In The Evaluation And Management Of Pulmonary Nodules

The Use of Blood-Based Biomarkers in the Evaluation and Management of Pulmonary Nodules

Evaluation and Management of Patients With Pulmonary Nodules

Using a Blood-Based Biomarker in Patients with Pulmonary Nodules in a Real-World Observational Study

Evaluating lung nodules during the COVID-19 pandemic using blood-based biomarkers

Using Biomarker-Based Risk Assessments to Inform Lung Nodule Referral Decisions

Pulmonary Nodules Imaging Analysis and Management

Radiology Video - radiology made esay

Sampling and Evaluating Lung Nodules and Masses: Expert Q&A

UChicago Medicine

Epidemiology and Management of the Solitary Pulmonary Nodule

ClevelandClinicCME

Reclassifying malignancy risk in indeterminate pulmonary nodules using Nodify Lung™ testing strategy

American Thoracic Society

WEBINAR REPLAY: Evolution of Clinical Evidence of the Blood-based Nodify Lung Nodule Risk Assessment

Lung Nodules: Four Things to Consider with Bryan Meyers, MD, MPH

Pulmonary Nodules

MedStar Georgetown Department of Medicine

Optimizing Diagnosis of Malignant Lung Nodules with the Use of Biomarker Testing and Robotic Bronch

The Changing Landscape of Pulmonary Nodule Management

GO2 for Lung Cancer

Lung Nodules (basics for patients)

Thoracic Radiology

Specific Lung Nodules & Masses | Chest Radiology Essentials

Radiology Frameworks

Nonspecific Lung Nodules & Masses | Chest Radiology Essentials

Radiology Frameworks

Cellvizio for the Assessment of Lung Nodules

Cellvizio by Mauna Kea Technologies

Enhanced Performance of the Nodify XL2 Blood-Based Lung Nodule Test

San Diego Community Connection Lung Nodule Evaluation and Biopsy

American Lung Association